Approvals/CIMA-AEMPS/DEFERASIROX PHARMATHEN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

DEFERASIROX PHARMATHEN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pharmathen S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e2150ca0a126b63c
Drug Cima Aemps Name: DEFERASIROX PHARMATHEN 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86889
Holder Company Name: Pharmathen S.A.
Marketing Company Name: Pharmathen S.A.
Holder Company Detail Path: /organization/pharmathen-s-a
Marketing Company Detail Path: /organization/pharmathen-s-a
Authorization Date: 2022-04-19
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 180 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Pharmathen S.A.
Company Detail Path: /organization/pharmathen-s-a

DEFERASIROX

180 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 19, 2022

Approval ID

e2150ca0a126b63c

Type

Standard